الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 136 |  |  |
| | | from | 136 | | |
Abstract
Background: Central line associated bloodstream infection is considered one of commonest complications that are associated with increased cost of care, extended hospital stay and increased mortality. Making an early and accurate diagnosis is critical for improving the prognosis in patients with CLABSI. Presepsin is a biological biomarker which has a good value in early detection of different infections.
Objective: to investigate the value of serum presepsin in diagnosis of CLABSI in adult patients admitted to intensive care units (ICUs).
Methodology: the study was conducted on 56 clinically suspected CLABSI cases, admitted to ICUs of Ain Shams University hospitals and 30 healthy individuals of matched age and sex as control group. Blood samples from patient were collected for conventional blood culture and for detection of 16S & 18S rDNA by nested multiplex PCR for negative samples by blood culture as well as for the quantitative measurement of serum presepsin levels by Human Presepsin ELISA kit for patients with confirmed CLABSI either by blood culture or multiplex PCR(n=30) and healthy controls(n=30).
Results: the most common isolated organism by blood culture was Klebsiella pneumoniae and enterococcus spp. (6/31, 19.4% for each). The mean value of serum presepsin among confirmed CLABSI cases was higher than healthy controls and the difference was statistically highly significant (819.33 ng/L versus 161.33 ng/L). Serum presepsin could be used to discriminate cases from controls at a cutoff level of ≥455ng/L.
Conclusion: serum presepsin is a promising biomarker that aids in early diagnosis of CLABSI, thus offering early antimicrobial treatment which leads to improving patients’ mortalities. Further studies on large scales are recommended to evaluate the prognostic value of serum presepsin in such critically ill patients and to monitor patients’ response to therapeutic actions.